(NASDAQ: PETS) Petmed Express's forecast annual revenue growth rate of 6.96% is not forecast to beat the US Pharmaceutical Retailers industry's average forecast revenue growth rate of 33.99%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 66.29%.
Petmed Express's revenue in 2026 is $182,670,000.On average, 3 Wall Street analysts forecast PETS's revenue for 2026 to be $4,345,156,505, with the lowest PETS revenue forecast at $4,174,808,565, and the highest PETS revenue forecast at $4,472,917,460. On average, 3 Wall Street analysts forecast PETS's revenue for 2027 to be $4,474,629,500, with the lowest PETS revenue forecast at $4,299,145,441, and the highest PETS revenue forecast at $4,606,242,544.
In 2028, PETS is forecast to generate $4,597,040,331 in revenue, with the lowest revenue forecast at $4,416,634,158 and the highest revenue forecast at $4,732,077,454.